All In Biotech

Drug Trial Radar · NCT06643728

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of Bimagrumab and Tirzepatide, Alone or in Combination, to Investigate the Efficacy and Safety in Adult Participants With Obesity or Overweight Without Type 2 Diabetes

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 252 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

252

Actual

Start

Oct 21, 2024

Primary completion

Jan 16, 2026

Study completion Oct 27, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Oct 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy and safety of Bimagrumab and Tirzepatide, alone or in combination, in adults with obesity or overweight, with at least one obesity related comorbidity, without Type 2 Diabetes. The study will last about 70 weeks.

Conditions

  • Obesity
  • Overweight

Interventions

  • BimagrumabDrug

    Administered SC

  • TirzepatideDrug

    Administered SC

  • Bimagrumab PlaceboDrug

    Administered SC

  • Tirzepatide PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Body WeightTime frame: Baseline, Week 24

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Pinnacle Research Group, LLC

    Anniston, Alabama

  • Central Research Associates

    Birmingham, Alabama

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • Clinical Neuroscience Solutions, Inc. dba CNS Healthcare

    Jacksonville, Florida

  • Altus Research

    Lake Worth, Florida

  • Suncoast Research Group

    Miami, Florida

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Great Lakes Clinical Trials - Ravenswood

    Chicago, Illinois

  • SKY Integrative Medical Center/SKYCRNG

    Ridgeland, Mississippi

  • Keystone Clinical Studies

    Plymouth Meeting, Pennsylvania

  • Eastside Research Associates

    Redmond, Washington

  • Rainier Clinical Research Center

    Renton, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.